Prade, Ronalyn .
HRN: 26-05-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2024
CEFUROXIME 500MG (TAB)
10/18/2024
10/25/2024
ORAL
500mg
BID
S/P NSD (ER Delivery)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes